Pinnacle Wealth Planning Services Inc. increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 21.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,954 shares of the healthcare conglomerate’s stock after purchasing an additional 1,059 shares during the period. Pinnacle Wealth Planning Services Inc.’s holdings in UnitedHealth Group were worth $3,036,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also modified their holdings of the company. Signature Estate & Investment Advisors LLC grew its position in shares of UnitedHealth Group by 1.2% in the first quarter. Signature Estate & Investment Advisors LLC now owns 1,606 shares of the healthcare conglomerate’s stock valued at $820,000 after purchasing an additional 19 shares during the period. Steph & Co. grew its position in shares of UnitedHealth Group by 1.6% in the first quarter. Steph & Co. now owns 1,290 shares of the healthcare conglomerate’s stock valued at $658,000 after purchasing an additional 20 shares during the period. Palisades Hudson Asset Management LP boosted its position in UnitedHealth Group by 2.0% during the fourth quarter. Palisades Hudson Asset Management LP now owns 1,078 shares of the healthcare conglomerate’s stock worth $542,000 after acquiring an additional 21 shares during the last quarter. Charter Oak Capital Management LLC boosted its position in UnitedHealth Group by 2.4% during the fourth quarter. Charter Oak Capital Management LLC now owns 881 shares of the healthcare conglomerate’s stock worth $442,000 after acquiring an additional 21 shares during the last quarter. Finally, Oxford Financial Group Ltd. boosted its position in UnitedHealth Group by 3.0% during the fourth quarter. Oxford Financial Group Ltd. now owns 720 shares of the healthcare conglomerate’s stock worth $362,000 after acquiring an additional 21 shares during the last quarter. 87.48% of the stock is owned by hedge funds and other institutional investors.
In related news, EVP Erin Mcsweeney sold 1,273 shares of the company’s stock in a transaction on Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total value of $635,227.00. Following the completion of the sale, the executive vice president now owns 8,104 shares in the company, valued at approximately $4,043,896. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the completion of the sale, the director now owns 1,215,000 shares of the company’s stock, valued at approximately $581,936,400. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,273 shares of company stock valued at $3,065,752. Company insiders own 0.40% of the company’s stock.
UNH has been the topic of a number of analyst reports. Cowen raised their target price on shares of UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $482.00 to $549.00 and gave the stock a “buy” rating in a research note on Monday, April 18th. Truist Financial lifted their target price on shares of UnitedHealth Group from $575.00 to $610.00 in a research note on Thursday, April 7th. Oppenheimer raised their target price on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock an “outperform” rating in a research note on Monday, April 18th. Finally, Raymond James boosted their price target on shares of UnitedHealth Group from $540.00 to $620.00 and gave the company a “strong-buy” rating in a research note on Tuesday, April 19th. Three analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $555.73.
NYSE UNH opened at $517.40 on Friday. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.54. UnitedHealth Group Incorporated has a 52 week low of $383.12 and a 52 week high of $553.29. The stock has a market capitalization of $485.41 billion, a PE ratio of 28.32, a price-to-earnings-growth ratio of 1.54 and a beta of 0.83. The firm has a 50 day moving average of $492.77 and a two-hundred day moving average of $492.62.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its quarterly earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, topping the consensus estimate of $5.40 by $0.09. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The company had revenue of $80.15 billion during the quarter, compared to analysts’ expectations of $78.77 billion. During the same quarter in the previous year, the business posted $5.31 EPS. The firm’s revenue was up 14.2% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Stockholders of record on Monday, June 20th were issued a $1.65 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date of this dividend was Thursday, June 16th. This represents a $6.60 annualized dividend and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio is currently 36.12%.
About UnitedHealth Group: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments. UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Featured Stories:
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.
.